CIGNA PATHWELL SPECIALTY
LIVE

Serial Number

97037986

Owner

CIGNA INTELLECTUAL PROPERTY, INC.

Filing Date

Sep 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CIGNA PATHWELL SPECIALTY Trademark

Serial Number: 97037986 • Registration: 7116336

CIGNA PATHWELL SPECIALTY is a trademark filed by CIGNA INTELLECTUAL PROPERTY, INC. on September 21, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CIGNA INTELLECTUAL PROPERTY, INC. (563 trademarks)

300 Bellevue Parkway
Wilmington, DE 19809

Entity Type: 03

Trademark Details

Filing Date

September 21, 2021

Registration Date

July 18, 2023

Published for Opposition

October 11, 2022

Goods & Services

Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription health care benefit coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurance, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify clinical benefits; prescription drug healthcare benefit plan services, namely, providing information to patients regarding in-network services in the fields of disease management programs and chronic conditions

Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs management and retail pharmacy services; Drug utilization review services and drug and medical formulary cost management services; pharmaceutical and medical cost management services and drug utilization review services; in-network provider advisory services and consultancy services, strategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management, and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior, and health care benefit plan healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans; cost management for pharmacy heath care benefit services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits to identify potential cost savings

Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; health care services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare and pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 14, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 13, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 9, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 5, 2023 AITU
USE AMENDMENT FILED
May 12, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
May 12, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 6, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 11, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 7, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 7, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 7, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 30, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2021 NWOS
NEW APPLICATION ENTERED
Sep 24, 2021 NWAP